Welcome Message

The “39th World Congress Conference on Heart Diseases” will take place on May 30-31, 2024 at Vienna, Austria and is open to all eminent scientists, young researchers, business delegates, academicians, presenters and students from around the world. Building on the success of our inaugural event, we are excited to bring together experts from around the world to explore the latest advancements in the field of cardiology.

As we gather in this historic city renowned for its cultural heritage, we invite you to join us for two days of immersive learning, collaboration, and inspiration. The conference serves as a global platform to exchange insights, present cutting-edge research, and discuss innovative approaches that are shaping the landscape of cardiovascular care.

About Conference

Heart Disease 2024 will focus on the theme “Promising Growth towards Cardiac Research” and it aims to accelerate scientific discoveries and major milestones in the current situation, trials, and advances in cardiology research and related fields. Cardiology practitioners from around the world will participate in the 2-day event, which will accommodate 1000+ global events, including 300+ conferences, 500+ upcoming and previous symposiums and technical sessions.

This conference will be a platform for association of cardiology professionals in all levels i.e. Deans, Directors, Department Heads, Professors, Eminent Scientists, Researchers, Students and Medical/pharma Companies, who will be joining together to share, gain and exchange knowledge and ideas for the better research and development in cardiology and its related fields.

We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on cardiology. It will be focussing on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.

Target Audience:

• Cardiologists and Cardiovascular Specialists
• Cardiac Surgeons
• Interventional Cardiologists
• Researchers and Scientists
• Nurses and Allied Health Professionals
• Medical Students and Residents
• Healthcare Administrators
• Pharmaceutical and Medical Device Companies
• Academic Institutions and Educators
• Global Health Organizations
• Medical Societies and Associations

Why to attend:

Heart Disease 2024 provides an international platform for the presentation of research about diagnosis, prevention and management and the exchange of ideas about them, contributing to the dissemination of knowledge in cardiology for the benefit of the academic community in addition to the business sector.

There will be plenary lectures, symposia, workshops on various topics, poster presentations, and various programs for participants from around the world during this Heart Disease Conference, which is geared up for an exciting and informative conference program.

Benefits of Attending:

• Knowledge Enrichment
• Expert Learning
• Networking Opportunities
• Interactive Workshops
• Scientific Exchange
• Multidisciplinary Insights
• Career Development
• Global Perspectives
• Inspiration and Motivation
• Exhibition Engagement

Sessions

Session 1: Cardiovascular Risk Factors and Prevention
Cardiovascular risk factors encompass a range of conditions and behaviors that increase the likelihood of developing heart diseases. These factors include hypertension, high cholesterol, smoking, obesity, physical inactivity, and diabetes. Prevention strategies focus on identifying, managing, and mitigating these risk factors through lifestyle modifications like adopting a healthy diet, engaging in regular exercise, and quitting smoking. Early detection and intervention play a critical role in preventing the progression of heart diseases. By addressing risk factors and promoting heart-healthy habits, individuals can significantly reduce their chances of experiencing heart-related complications, ultimately leading to better heart health and improved quality of life.

Session 2: Coronary Artery Disease (CAD) and Atherosclerosis
Coronary Artery Disease (CAD) is a condition where the blood vessels supplying the heart muscle become narrowed or blocked due to the buildup of plaque, a fatty substance. This plaque accumulation, known as atherosclerosis, restricts blood flow to the heart, leading to chest pain (angina) or potentially causing heart attacks. Atherosclerosis involves the gradual deposition of cholesterol, inflammatory cells, and other materials within the arterial walls. As the plaque grows, it can limit the supply of oxygen and nutrients to the heart muscle. Understanding the mechanisms of CAD and atherosclerosis is crucial for developing effective prevention strategies and innovative treatments, ranging from lifestyle changes and medications to interventional procedures like stents and bypass surgeries.

Session 3: Heart Failure and Cardiomyopathies
Heart failure refers to a condition where the heart's ability to pump blood efficiently is compromised, leading to inadequate circulation and oxygen delivery to the body's tissues. Cardiomyopathies are a group of diseases that affect the heart muscle, impairing its ability to contract and relax effectively. These conditions can result from various causes, including genetic factors, infections, or underlying health conditions. Heart failure and cardiomyopathies present a range of symptoms, including fatigue, shortness of breath, and fluid retention. Management approaches include medications, lifestyle changes, and in severe cases, interventions like heart transplantation or the use of ventricular assist devices. Understanding the intricacies of heart failure and cardiomyopathies is vital for providing optimal care to affected individuals and improving their quality of life.

Session 4: Arrhythmias and Electrophysiology
Arrhythmias are irregular heart rhythms that can disrupt the heart's normal pumping function. Electrophysiology is the study of the heart's electrical system that controls its rhythm. Arrhythmias can range from benign to life-threatening, affecting heart rate and coordination. Electrophysiology studies involve mapping the heart's electrical signals and diagnosing the source of arrhythmias. Treatments may include medications, implantable devices like pacemakers or defibrillators, and catheter-based interventions such as ablation to correct abnormal electrical pathways. Understanding arrhythmias and electrophysiology is essential for effective diagnosis, risk assessment, and management of these conditions, ensuring proper heart function and preventing potentially serious complications.

Session 5: Interventional Cardiology and Catheter-Based Therapies
Interventional cardiology involves minimally invasive procedures to diagnose and treat heart conditions using catheters guided by imaging technology. Catheter-based therapies include angioplasty, where narrowed or blocked arteries are widened using balloons, and stents, which are small mesh tubes placed to keep arteries open. These procedures are used to treat conditions like coronary artery disease, heart valve issues, and structural heart defects. They offer faster recovery, reduced risks, and shorter hospital stays compared to traditional surgeries. Interventional cardiology has revolutionized cardiovascular care, providing effective alternatives to open-heart surgeries and enabling patients to regain heart health with minimal invasiveness.

Session 6: Imaging Modalities in Cardiology
Imaging modalities are advanced techniques used to visualize the structure and function of the heart for accurate diagnosis and treatment planning. These include echocardiography, which uses sound waves to create detailed images of the heart's chambers and valves; cardiac MRI, providing high-resolution images of the heart's anatomy and function; and cardiac CT scans, offering 3D views of the heart and blood vessels. These non-invasive methods aid in detecting heart diseases, assessing heart function, and guiding interventions. Imaging modalities play a pivotal role in personalized patient care, enabling healthcare professionals to make informed decisions and monitor treatment progress with precision.

Session 7: Cardiovascular Genetics and Precision Medicine
Cardiovascular genetics explores the role of genetic factors in influencing heart diseases, identifying genetic mutations that contribute to conditions such as arrhythmias, cardiomyopathies, and familial hypercholesterolemia. Precision medicine tailors treatment approaches based on an individual's genetic makeup, considering genetic variations that impact drug responses and disease risks. By analyzing genetic information, healthcare providers can predict disease susceptibility and customize therapies for optimal outcomes. This approach revolutionizes cardiovascular care, enabling early detection, targeted interventions, and more effective management strategies that address the unique genetic underpinnings of each patient's condition.

Session 8: Pediatric and Congenital Heart Diseases
This track focuses on heart conditions affecting infants, children, and adolescents, including congenital heart defects present at birth. The sessions cover a wide range of topics, from prenatal diagnosis and neonatal care to surgical interventions and long-term management strategies. Advances in surgical techniques, imaging, and pediatric cardiology have significantly improved outcomes for young patients with heart conditions. The track aims to provide a comprehensive understanding of these specialized areas, allowing healthcare professionals to offer the best possible care to pediatric and congenital heart disease patients, ensuring their healthy growth and development.

Session 9: Vascular Diseases and Peripheral Arterial Disorders
This track delves into conditions affecting blood vessels beyond the heart, including peripheral arterial diseases that restrict blood flow to the limbs. Discussions cover atherosclerosis in arteries supplying the legs, leading to pain, ulcers, and gangrene. Emerging diagnostic tools, such as vascular imaging techniques, aid in early detection and assessment. Treatment options range from lifestyle modifications and medications to interventions like angioplasty and stent placement to restore blood flow. The track offers insights into managing vascular diseases, addressing complications, and improving patient outcomes, thereby enhancing the quality of life for individuals affected by these conditions.

Session 10: Cardio-Oncology and Heart Health in Cancer Patients
This specialized track focuses on the intersection of cardiovascular health and cancer care, recognizing that cancer treatments can impact the heart. Discussions cover the cardiotoxic effects of chemotherapy and radiation, emphasizing strategies to mitigate risks and monitor heart health during cancer treatment. Cardio-oncology involves close collaboration between cardiologists and oncologists to ensure optimal patient outcomes. The track highlights early detection, cardioprotective measures, and tailored interventions for individuals facing both cancer and heart concerns. By addressing the unique challenges at this intersection, healthcare professionals can provide comprehensive care that supports both cancer treatment and cardiovascular well-being.

Session 11: Women's Cardiovascular Health
This track sheds light on gender-specific aspects of heart diseases, recognizing that women often present with different symptoms and risk factors than men. Discussions encompass heart disease prevention, diagnosis, and treatment tailored to the unique needs of women. Topics range from hormonal influences on heart health to the impact of pregnancy-related conditions on long-term cardiovascular well-being. Addressing disparities in diagnosis and treatment, the track empowers healthcare professionals to provide specialized care that considers the distinct cardiovascular challenges women may face. By focusing on women's cardiovascular health, this track aims to improve outcomes and enhance the quality of life for female patients.

Session 12: Innovations in Heart Transplantation and Mechanical Circulatory Support
This track highlights cutting-edge advancements in heart transplantation and mechanical circulatory support, offering insights into the latest techniques, organ preservation methods, and patient selection criteria for heart transplant recipients. Discussions also delve into ventricular assist devices (VADs) and artificial hearts, exploring their evolving roles as bridges to transplantation or even as long-term therapeutic options. The track showcases breakthroughs that enhance the success rates and quality of life for patients with end-stage heart failure. By exploring innovative solutions, healthcare professionals gain the tools to provide optimal care to individuals awaiting transplantation or seeking alternatives to traditional therapies.

Session 13: Diabetes and Cardiometabolic Health
This track delves into the intricate relationship between diabetes and cardiovascular health, addressing the impact of diabetes on heart disease risk and management. Discussions cover how diabetes contributes to a range of cardiometabolic conditions, including hypertension, dyslipidemia, and obesity. The track explores strategies to manage both diabetes and its associated cardiovascular risks, focusing on lifestyle modifications, medication approaches, and integrated care models. By understanding the interplay between these conditions, healthcare professionals can provide comprehensive care that improves not only glycemic control but also overall cardiovascular outcomes for patients with diabetes.

Session 14: Clinical Cardiology
Clinical cardiology is a specialized branch of medicine dedicated to the study, diagnosis, and treatment of heart-related diseases and conditions. Cardiologists, the medical professionals in this field, are trained to assess and manage a wide range of cardiovascular issues, including heart attacks, arrhythmias, heart failure, and congenital heart defects.They utilize various diagnostic tools such as electrocardiograms (ECGs), echocardiography, stress tests, and cardiac catheterization to evaluate heart health and make informed treatment decisions.

Clinical cardiology plays a crucial role in improving patient outcomes by developing tailored treatment plans, prescribing medications, recommending lifestyle modifications, and, when necessary, performing interventional procedures like angioplasty or stent placement to restore blood flow to the heart.

Cardiologists also educate patients on heart disease prevention and risk factors, emphasizing the importance of a healthy diet, regular exercise, and smoking cessation.

The field is dynamic and continuously evolving, with ongoing research into innovative therapies, advancements in technology, and a focus on personalized medicine to provide the best possible care to individuals with heart conditions.

Session 15: Preventive Cardiology and Lifestyle Interventions
Preventive cardiology is a specialized branch of clinical cardiology that focuses on identifying and mitigating risk factors associated with heart disease before they lead to serious cardiovascular events. It emphasizes a proactive, patient-centered approach to heart health, with a primary goal of preventing heart disease rather than just treating its symptoms. Lifestyle interventions are a cornerstone of preventive cardiology, offering individuals the opportunity to take control of their heart health through sustainable changes in their daily habits and behaviors.

Key Components of Preventive Cardiology:

• Risk Assessment
• Lifestyle Modifications
• Dietary Strategies
• Physical Activity
• Smoking Cessation
• Medication Management
• Behavioral Counseling
• Regular Monitoring

The Importance of Lifestyle Interventions:
Lifestyle interventions are pivotal in preventive cardiology because they empower individuals to take control of their heart health. By adopting heart-healthy behaviors and making sustainable lifestyle changes, individuals can significantly reduce their risk of heart disease, even if they have existing risk factors.

Ultimately, preventive cardiology and lifestyle interventions promote the idea that heart disease is largely preventable. Through education, support, and a holistic approach to health, we can work together to reduce the global burden of cardiovascular diseases and help individuals lead longer, healthier lives.

Market Analysis

The mechanical heart valve market was led by aortic procedures in 2020. Growth, however, will not occur as this market is currently decreasing over the forecast period. These heart valves were rarely used to replace the tricuspid or pulmonary valves, and as a result, unit sales are decreasing. The largest limiter within this market is the need for anticoagulant therapy for the remainder of the patient’s life after the procedure. Despite this, advancements in technology surrounding the development of biocompatible polymers to reduce the formation of blood clots are underway. Patients would no longer need to use anti-coagulants and because of this, the market could experience growth.

Benefits of Participation

Advantages of Participating at Heart Disease 2024:

• The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our Conference.
• Best Speaker, Poster Award nominations.
• Award for Outstanding Young Researcher.
• Discounts on Group Registrations.
• Knowledge Advancement: Access the latest research findings, developments, and advancements in cardiology and vascular care.
• Networking Opportunities: Connect with renowned experts, healthcare professionals, and researchers in the field.
• Professional Growth: Gain insights from thought leaders, enhancing your skills and expertise.
• Research Collaboration: Discover opportunities for collaboration and partnership on innovative projects.
• Stay Informed: Stay up-to-date with industry trends and emerging technologies.
• Inspiration: Be inspired by groundbreaking discoveries and success stories in cardiovascular healthcare.

Benefits of Participation for Speaker:

• Visibility: Showcase your expertise and research to a global audience of peers and professionals.
• Thought Leadership: Establish yourself as a thought leader in the field of cardiology.
• Networking: Build valuable connections with fellow speakers, researchers, and healthcare professionals.
• Professional Development: Refine your presentation and communication skills.
• Contribution: Contribute to the advancement of knowledge in cardiology and vascular care.

Benefits of Participation for Delegate:

• Education: Attend sessions led by experts and gain in-depth knowledge on various topics.
• Networking: Connect with professionals, researchers, and peers from diverse backgrounds.
• New Insights: Learn about the latest research, trends, and best practices in cardiovascular healthcare.
• Interactive Workshops: Participate in hands-on workshops to enhance practical skills.
• Career Opportunities: Discover potential career opportunities and collaborations.

Benefits of Participation for Sponsor:

• Brand Exposure: Increase brand visibility among a targeted audience of healthcare professionals.
• Lead Generation: Access a pool of potential clients, collaborators, and partners.
• Thought Leadership: Showcase industry leadership and expertise through sponsorship.
• Networking: Engage with delegates and speakers, fostering valuable connections.
• Customized Engagement: Tailor sponsorship packages to meet specific marketing goals.
• Market Research: Gain insights into market trends and consumer preferences.